Jacqueline Corrigan-Curay, who stepped into the role as the agency’s top drug regular in January, is departing in July, according to an email sent to agency staff.
Jacqueline Corrigan-Curay, who stepped into the role as the agency’s top drug regular in January, is departing in July, according to an email sent to agency staff.